About
Preeclampsia Test
Areas of Focus
Categories
DiagnosticsNorth & South Carolina
Clinical Trials (24)
View allTotal Trials
24
As Lead Sponsor
15
As Collaborator
9
Total Enrollment
16,368
By Phase
NA: 7PHASE2: 5PHASE3: 1PHASE1: 5PHASE4: 2EARLY_PHASE1: 1
By Status
COMPLETED: 15RECRUITING: 3UNKNOWN: 3TERMINATED: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06402786Collaborator
First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery.
NARecruiting
20 participants
Started: May 27, 2024 · Completed: Dec 31, 2025
NCT05950282Lead Sponsor
Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
N/ARecruiting
500 participants
Started: Feb 1, 2024 · Completed: Dec 31, 2026
NCT05861674Lead Sponsor
A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection
PHASE2Completed
101 participants
Started: Jun 16, 2023 · Completed: Jun 21, 2025
NCT05787418Lead Sponsor
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
PHASE3Enrolling by invitation
1,200 participants
Started: Mar 31, 2023 · Completed: Apr 1, 2026
NCT05713318Lead Sponsor
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
PHASE2Completed
200 participants
Started: Jan 18, 2023 · Completed: Jun 19, 2023
Locations (1)
Headquarters
Chapel Hill, NC, United States
Map
Loading map...